Neuropathic pain is a dreadful and debilitating chronic pain state that occurs following injury to the nervous system. Both peripheral and central mechanisms regarding the pathogenesis of neuropathic pain have been proposed. The central glutamatergic system has been a focus of intense research interest for over a decade and a large body of compelling evidence has emerged that indicates a critical role of this system in the neural mechanisms of neuropathic pain. The involvement of the glutamatergic system in neuropathic pain could result from changes in glutamate uptake as well as from persistent and abnormal activation of glutamate receptors and their related intracellular cascades. To date, much effort has been made to investigate contributions of modulating glutamate receptor activation and the associated intracellular cascades to the mechanisms of neuropathic pain. Little is known about the role of regulating the homeostasis of endogenous ligands of glutamate receptors, primarily glutamate itself, in the pathogenesis of neuropathic pain. It has been well documented that the homeostasis of extracellular glutamate is actively and tightly regulated by neuronal and glial glutamate transporters (GTs), which prevents glutamate-mediated neuronal over excitation and neurotoxicity that may play a critical role in a wide range of neurological disorders including those following nerve injury. Our recent studies have demonstrated that both expression and glutamate uptake activity of spinal GTs are altered following peripheral nerve injury and contribute to the induction and maintenance of neuropathic pain behaviors in rats. In this application, we propose to systematically investigate the role of modulating spinal GTs in the pathogenesis of neuropathic pain utilizing an experimental neuropathic pain model. Our main hypothesis is that peripheral nerve injury would alter the expression and glutamate uptake activity of spinal GTs via distinct regulatory mechanisms mediated through such factors as neurotrophic factors, mitogen-activated protein kinases, arachidonic acids, nitric oxide, and glutamate itself. The GT changes would in turn regulate regional glutamate homeostasis and contribute to the pathogenesis of neuropathic pain. This main hypothesis will be examined by utilizing multidisciplinary methods including behavioral and pharmacological evaluation, immunocytochemistry, Western blot, in situ hybridization, RNase protection assay, and assays of glutamate uptake and regional glutamate concentration, to accomplish three specific aims: (1) to examine changes of spinal GT expression and glutamate uptake activity in a neuropathic pain state; (2) to explore the cellular and molecular mechanisms leading to spinal GT changes in a neuropathic pain state; and (3) to investigate contributions of regulating spinal GTs to the development and maintenance of neuropathic pain. This proposed work would yield novel information regarding the role of regulating glutamate uptake in the pathogenesis of neuropathic pain. Importantly, understanding contributions of regulating glutamate uptake to the mechanisms of neuropathic pain would open a new avenue to developing novel pharmacological tools that could improve the clinical management of often debilitating neuropathic pain syndromes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS045681-03
Application #
6984754
Study Section
Integrative, Functional and Cognitive Neuroscience 8 (IFCN)
Program Officer
Porter, Linda L
Project Start
2003-12-01
Project End
2007-11-30
Budget Start
2005-12-01
Budget End
2006-11-30
Support Year
3
Fiscal Year
2006
Total Cost
$354,941
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Mao, Jianren; Gold, Michael S; Backonja, Miroslav Misha (2011) Combination drug therapy for chronic pain: a call for more clinical studies. J Pain 12:157-66
Chou, Chiu-Wen; Wong, Gordon T C; Lim, Grewo et al. (2011) Peripheral nerve injury alters the expression of NF-ýýB in the rat's hippocampus. Brain Res 1378:66-71
Chou, Chiu-Wen; Wong, Gordon T C; Lim, Grewo et al. (2011) Spatiotemporal pattern of concurrent spinal and supraspinal NF-?B expression after peripheral nerve injury. J Pain 12:13-21
Kim, Hyangin; Oh, Saecheol; Sung, Backil et al. (2010) Anti-morphine antibody contributes to the development of morphine tolerance in rats. Neurosci Lett 480:196-200
Wang, Shuxing; Lim, Grewo; Mao, Ji et al. (2009) Regulation of the trigeminal NR1 subunit expression induced by inflammation of the temporomandibular joint region in rats. Pain 141:97-103
Lim, Grewo; Wang, Shuxing; Zhang, Yi et al. (2009) Spinal leptin contributes to the pathogenesis of neuropathic pain in rodents. J Clin Invest 119:295-304
Mao, Jianren (2009) Translational pain research: achievements and challenges. J Pain 10:1001-11
Wang, Shuxing; Zhang, Lin; Lim, Grewo et al. (2009) A combined effect of dextromethorphan and melatonin on neuropathic pain behavior in rats. Brain Res 1288:42-9
Hernstadt, Hayley; Wang, Shuxing; Lim, Grewo et al. (2009) Spinal translocator protein (TSPO) modulates pain behavior in rats with CFA-induced monoarthritis. Brain Res 1286:42-52
Yang, Liling; Wang, Shuxing; Sung, Backil et al. (2008) Morphine induces ubiquitin-proteasome activity and glutamate transporter degradation. J Biol Chem 283:21703-13

Showing the most recent 10 out of 30 publications